Model‐based meta‐analysis to quantify the effects of short interfering RNA therapeutics on hepatitis B surface antigen turnover in hepatitis B‐infected mice

Documenti analoghi

• Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model
  di: Toshiaki Tsuchitani, et al.
  Pubblicazione: (2024)
• Translational kinetic‐pharmacodynamics of mRNA‐6231, an investigational mRNA therapeutic encoding mutein interleukin‐2
  di: Ivana Liric Rajlic, et al.
  Pubblicazione: (2024)
• Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma
  di: Per Olsson Gisleskog, et al.
  Pubblicazione: (2025)
• Clofazimine pharmacokinetics in HIV‐infected adults with diarrhea: Implications of diarrheal disease on absorption of orally administered therapeutics
  di: Cindy X. Zhang, et al.
  Pubblicazione: (2024)
• Clinical study design strategies to mitigate confounding effects of time‐dependent clearance on dose optimization of therapeutic antibodies
  di: Jeffrey R. Proctor, et al.
  Pubblicazione: (2024)